Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx May Take Back Seat To “Corporate Responsibility”

Executive Summary

The renewed focus on corporate accounting issues may bring to an end the already slim chances that a Medicare prescription drug benefit will be enacted into law during 2002
Advertisement

Related Content

AdvancePCS Gives 80% Of Rebates To Clients, Sees Discounts Increasing
AdvancePCS Gives 80% Of Rebates To Clients, Sees Discounts Increasing
Rx Rebates, Gifts To Physicians Would Be Public Under Torricelli Proposal
Rx Rebates, Gifts To Physicians Would Be Public Under Torricelli Proposal
Medco IPO Delay: Merck Trades Gross Margin For Cloudy Rebate Calculations
Medco IPO Delay: Merck Trades Gross Margin For Cloudy Rebate Calculations
Medco IPO Delay: Merck Trades Gross Margin For Cloudy Rebate Calculations
Rite Aid Allegations Include Booking Unearned Rx Rebates By Former Exec
FDA Oncology Reviews Need Common “Best Practices” – Erbitux Follow-Up
Advertisement
UsernamePublicRestriction

Register

PS040157

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel